<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Orforglipron</title><link>https://peptidescanner.com/peptides/orforglipron/</link><description>Versioned, source-linked PeptideScanner evidence objects for Orforglipron. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/orforglipron.xml" rel="self" type="application/rss+xml"/><item><title>Drugs@FDA application NDA220934</title><link>https://peptidescanner.com/stories/fda-drugs-nda220934/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda220934:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#fda-drugs-nda220934-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2026-04-01. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05869903</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05869903-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05869903-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05869903-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05872620</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05872620-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05872620-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05872620-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05931380</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05931380-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05931380-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05931380-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05971940</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05971940-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05971940-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05971940-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06010004</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06010004-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06010004-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06010004-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-06-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06109311</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06109311-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06109311-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06109311-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-01. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06186622</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06186622-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06186622-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06186622-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-05-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06192108</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06192108-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06192108-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06192108-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06370728</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06370728-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06370728-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06370728-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06440980</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06440980-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06440980-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06440980-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06649045</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06649045-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06649045-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06649045-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-09-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06672549</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06672549-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06672549-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06672549-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06672939</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06672939-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06672939-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06672939-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06704763</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06704763-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06704763-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06704763-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-05-26. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06972459</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06972459-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06972459-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06972459-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06993792</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06993792-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06993792-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06993792-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07153471</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07153471-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07153471-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07153471-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07202884</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07202884-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07202884-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07202884-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07223593</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07223593-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07223593-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07223593-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07241390</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07241390-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07241390-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07241390-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07613307</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07613307-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07613307-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07613307-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07729332</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07729332-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07729332-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07729332-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07739537</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07739537-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07739537-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07739537-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07790861</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07790861-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07790861-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07790861-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07794579</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07794579-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07794579-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07794579-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38091541-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38091541-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-38091541-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38091542-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38091542-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-38091542-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-03. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38091543-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38091543-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-38091543-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41994902-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41994902-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-41994902-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Orforglipron Calcium.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42138709-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42138709-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-42138709-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-07-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Orforglipron (Foundayo) for adults with obesity.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42420063-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42420063-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-42420063-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Orforglipron for Obstructive Sleep Apnea: Research Summary.</title><link>https://peptidescanner.com/stories/pubmed-pmid-43002163-orforglipron/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-43002163-orforglipron:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-43002163-orforglipron-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
